Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large <scp>B</scp>‐cell lymphoma in the rituximab eraReina Watanabe, Yoshiaki Ishigatsubo, Rika Ohshima et al.|European Journal Of Haematology|2013Cited by 58
Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapyKazuho Miyashita, Yoshiaki Ishigatsubo, Naoto Tomita et al.|Leukemia Research|2015Cited by 35
Prognostic significance of serum beta-2 microglobulin level in Hodgkin lymphoma treated with ABVD-based therapyYuki Nakajima, Yoshiaki Ishigatsubo, Naoto Tomita et al.|Medical Oncology|2014Cited by 15
Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapyYuki Nakajima, Yoshiaki Ishigatsubo, Naoto Tomita et al.|Leukemia Research|2014Cited by 12
Serum Beta-2 Microglobulin Level As a Useful Prognostic Marker Of Hodgkin LymphomaYuki Nakajima, Yoshiaki Ishigatsubo, Naoto Tomita et al.|Blood|2013Cited by 4